| Year |
Citation |
Score |
| 2019 |
Huang A, Garraway LA, Ashworth A, Weber B. Synthetic lethality as an engine for cancer drug target discovery. Nature Reviews. Drug Discovery. PMID 31712683 DOI: 10.1038/S41573-019-0046-Z |
0.424 |
|
| 2018 |
Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, ... ... Weber B, et al. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nature Communications. 9: 4181. PMID 30327465 DOI: 10.1038/S41467-018-06616-0 |
0.479 |
|
| 2017 |
Hu Z, Mao JH, Curtis C, Huang G, Gu S, Heiser L, Lenburg ME, Korkola JE, Bayani N, Samarajiwa S, Seoane JA, Dane MA, Esch A, Feiler HS, Wang NJ, ... ... Weber B, et al. Erratum to: Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Research : Bcr. 19: 17. PMID 28183333 DOI: 10.1186/S13058-017-0809-6 |
0.328 |
|
| 2016 |
Hu Z, Mao JH, Curtis C, Huang G, Gu S, Heiser L, Lenburg ME, Korkola JE, Bayani N, Samarajiwa S, Seoane JA, A Dane M, Esch A, Feiler HS, Wang NJ, ... ... Weber B, et al. Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Research : Bcr. 18: 70. PMID 27368372 DOI: 10.1186/S13058-016-0728-Y |
0.399 |
|
| 2012 |
Li N, Kaur S, Greshock J, Lassus H, Zhong X, Wang Y, Leminen A, Shao Z, Hu X, Liang S, Katsaros D, Huang Q, Bützow R, Weber BL, Coukos G, et al. A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer. Cancer Research. 72: 154-64. PMID 22058146 DOI: 10.1158/0008-5472.Can-11-2484 |
0.303 |
|
| 2011 |
Maxwell CA, Benítez J, Gómez-Baldó L, Osorio A, Bonifaci N, Fernández-Ramires R, Costes SV, Guinó E, Chen H, Evans GJ, Mohan P, Català I, Petit A, Aguilar H, Villanueva A, ... ... Weber BL, et al. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. Plos Biology. 9: e1001199. PMID 22110403 DOI: 10.1371/Journal.Pbio.1001199 |
0.452 |
|
| 2011 |
Huang J, Zhang L, Greshock J, Colligon TA, Wang Y, Ward R, Katsaros D, Lassus H, Butzow R, Godwin AK, Testa JR, Nathanson KL, Gimotty PA, Coukos G, Weber BL, et al. Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes, Chromosomes & Cancer. 50: 606-18. PMID 21563232 DOI: 10.1002/Gcc.20883 |
0.45 |
|
| 2010 |
Degenhardt Y, Greshock J, Laquerre S, Gilmartin AG, Jing J, Richter M, Zhang X, Bleam M, Halsey W, Hughes A, Moy C, Liu-Sullivan N, Powers S, Bachman K, Jackson J, ... Weber B, et al. Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability. Molecular Cancer Therapeutics. 9: 2079-89. PMID 20571075 DOI: 10.1158/1535-7163.Mct-10-0095 |
0.38 |
|
| 2010 |
Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, Benezra M, Licht JD, Boudreau NJ, Tsai KK, Welm AL, Feldman MD, Weber BL, Weaver VM. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. The Journal of Clinical Investigation. 120: 1535-50. PMID 20389018 DOI: 10.1172/Jci39534 |
0.729 |
|
| 2010 |
Balamuth NJ, Wood A, Wang Q, Jagannathan J, Mayes P, Zhang Z, Chen Z, Rappaport E, Courtright J, Pawel B, Weber B, Wooster R, Sekyere EO, Marshall GM, Maris JM. Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target. Cancer Research. 70: 2749-58. PMID 20233875 DOI: 10.1158/0008-5472.Can-09-3844 |
0.349 |
|
| 2009 |
Heiser LM, Wang NJ, Talcott CL, Laderoute KR, Knapp M, Guan Y, Hu Z, Ziyad S, Weber BL, Laquerre S, Jackson JR, Wooster RF, Kuo WL, Gray JW, Spellman PT. Integrated analysis of breast cancer cell lines reveals unique signaling pathways. Genome Biology. 10: R31. PMID 19317917 DOI: 10.1186/Gb-2009-10-3-R31 |
0.501 |
|
| 2009 |
Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, Naylor TL, Weber BL, Fakharzadeh SS, Weinstein GS, Vachani A, et al. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biology & Therapy. 8: 907-16. PMID 19276661 DOI: 10.4161/Cbt.8.10.8132 |
0.408 |
|
| 2009 |
Greshock J, Nathanson K, Medina A, Ward MR, Herlyn M, Weber BL, Zaks TZ. Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines. Genes, Chromosomes & Cancer. 48: 419-28. PMID 19226609 DOI: 10.1002/Gcc.20651 |
0.391 |
|
| 2009 |
Meraner V, Giesinger J, Kemmler G, Taucher S, Hubalek M, Weber B, Rumpold G, Sperner-Unterweger B, Holzner B. Development of a screening tool for the identification of psychooncological treatment need in breast cancer patients. Psycho-Oncology. 18: 974-83. PMID 19142844 DOI: 10.1002/pon.1480 |
0.322 |
|
| 2009 |
Yin H, Kiefer J, Chow D, Que QQ, Dastrup E, Weber B, Wooster R, Mousses S. Abstract PR-10: RNAi‐directed identification of chemosensitizers of GSK923295 response Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-Pr-10 |
0.326 |
|
| 2009 |
Hu Z, Mao J, Huang G, Kuo W, Lenburg M, Ziyad S, Korkola J, Bayani N, Wang N, Gu S, Weber B, Wooster R, Gray J. A Systems Analysis of Mitotic Apparatus Inhibitors Defines a Response Network for Breast Cancer. Cancer Research. 69: 2020-2020. DOI: 10.1158/0008-5472.Sabcs-09-2020 |
0.423 |
|
| 2008 |
Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, Liang S, Leminen A, Deng S, Smith L, Johnstone CN, Chen XM, Liu CG, Huang Q, Katsaros D, ... ... Weber BL, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Research. 68: 10307-14. PMID 19074899 DOI: 10.1158/0008-5472.Can-08-1954 |
0.357 |
|
| 2008 |
Tchou J, Greshock J, Bergey MR, Sonnad SS, Sargen M, Weinstein S, Czerniecki BJ, Boraas M, Fraker DL, Rosato E, Fox K, Weber B, Solin LJ. Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast cancer. Clinical Breast Cancer. 8: 143-8. PMID 18621610 DOI: 10.3816/Cbc.2008.N.014 |
0.516 |
|
| 2008 |
Greshock J, Cheng J, Rusnak D, Martin AM, Wooster R, Gilmer T, Lee K, Weber BL, Zaks T. Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines. Molecular Cancer Therapeutics. 7: 935-43. PMID 18413807 DOI: 10.1158/1535-7163.Mct-07-2072 |
0.369 |
|
| 2008 |
Finlay E, Stopfer JE, Burlingame E, Evans KG, Nathanson KL, Weber BL, Armstrong K, Rebbeck TR, Domchek SM. Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing. 12: 81-91. PMID 18373407 DOI: 10.1089/Gte.2007.0037 |
0.4 |
|
| 2008 |
Domchek S, Weber BL. Genetic variants of uncertain significance: flies in the ointment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 16-7. PMID 18165634 DOI: 10.1200/Jco.2007.14.4154 |
0.541 |
|
| 2007 |
Melchor L, Honrado E, Huang J, Alvarez S, Naylor TL, García MJ, Osorio A, Blesa D, Stratton MR, Weber BL, Cigudosa JC, Rahman N, Nathanson KL, Benítez J. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7305-13. PMID 18094411 DOI: 10.1158/1078-0432.Ccr-07-0711 |
0.571 |
|
| 2007 |
Greshock J, Feng B, Nogueira C, Ivanova E, Perna I, Nathanson K, Protopopov A, Weber BL, Chin L. A comparison of DNA copy number profiling platforms. Cancer Research. 67: 10173-80. PMID 17968032 DOI: 10.1158/0008-5472.Can-07-2102 |
0.347 |
|
| 2007 |
Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, Assmann V, Elshamy WM, Rual JF, Levine D, Rozek LS, ... ... Weber BL, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature Genetics. 39: 1338-49. PMID 17922014 DOI: 10.1038/Ng.2007.2 |
0.522 |
|
| 2007 |
Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, et al. Validity of models for predicting BRCA1 and BRCA2 mutations. Annals of Internal Medicine. 147: 441-50. PMID 17909205 DOI: 10.7326/0003-4819-147-7-200710020-00002 |
0.505 |
|
| 2007 |
Zhang L, Huang J, Yang N, Greshock J, Liang S, Hasegawa K, Giannakakis A, Poulos N, O'Brien-Jenkins A, Katsaros D, Butzow R, Weber BL, Coukos G. Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5314-21. PMID 17875760 DOI: 10.1158/1078-0432.Ccr-06-2660 |
0.417 |
|
| 2007 |
Tchou J, Ward MR, Volpe P, Palma MD, Medina CA, Sargen M, Sonnad SS, Godwin AK, Daly M, Winchester DJ, Garber J, Weber BL, Domchek S, Nathanson KL. Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clinical Breast Cancer. 7: 627-33. PMID 17592676 DOI: 10.3816/Cbc.2007.N.021 |
0.573 |
|
| 2007 |
Quraishi I, Rishi M, Feldman M, Wargovich MJ, Weber B. Clinical validation of breast cancer biomarkers using tissue microarray technology. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 15: 45-9. PMID 17536306 DOI: 10.1097/01.Pai.0000213129.86288.34 |
0.486 |
|
| 2007 |
Greshock J, Nathanson K, Martin AM, Zhang L, Coukos G, Weber BL, Zaks TZ. Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization. Cancer Research. 67: 3594-600. PMID 17440070 DOI: 10.1158/0008-5472.Can-06-3674 |
0.367 |
|
| 2007 |
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, ... ... Weber BL, et al. Patterns of somatic mutation in human cancer genomes. Nature. 446: 153-8. PMID 17344846 DOI: 10.1038/Nature05610 |
0.502 |
|
| 2007 |
Zhang L, Huang J, Yang N, Greshock J, Megraw M, Giannakakis A, Liang S, Naylor T, Barchetti A, Ward M, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, ... ... Weber B, et al. MICRORNAS EXHIBIT HIGH FREQUENCY GENO-MIC ALTERATIONS IN HUMAN OVARIAN CANCER Biology of Reproduction. 77: 66-66. DOI: 10.1093/Biolreprod/77.S1.66 |
0.359 |
|
| 2006 |
Thompson D, Seal S, Schutte M, McGuffog L, Barfoot R, Renwick A, Eeles R, Sodha N, Houlston R, Shanley S, Klijn J, Wasielewski M, Chang-Claude J, Futreal PA, Weber BL, et al. A multicenter study of cancer incidence in CHEK2 1100delC mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 2542-5. PMID 17164383 DOI: 10.1158/1055-9965.Epi-06-0687 |
0.423 |
|
| 2006 |
Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C, Mackay A, Grigoriadis A, Sarrio D, Savage K, Dexter T, Iravani M, Fenwick K, Weber B, Hardisson D, Schmitt FC, et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6652-62. PMID 17121884 DOI: 10.1158/1078-0432.Ccr-06-1164 |
0.391 |
|
| 2006 |
Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K, et al. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 4642-60. PMID 17008706 DOI: 10.1200/Jco.2005.04.5260 |
0.48 |
|
| 2006 |
Guillem JG, Wood WC, Moley JF, Berchuck A, Karlan BY, Mutch DG, Gagel RF, Weitzel J, Morrow M, Weber BL, Giardiello F, Rodriguez-Bigas MA, Church J, Gruber S, Offit K. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes. Annals of Surgical Oncology. 13: 1296-321. PMID 16990987 DOI: 10.1245/S10434-006-9036-6 |
0.44 |
|
| 2006 |
Diskin SJ, Eck T, Greshock J, Mosse YP, Naylor T, Stoeckert CJ, Weber BL, Maris JM, Grant GR. STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments. Genome Research. 16: 1149-58. PMID 16899652 DOI: 10.1101/Gr.5076506 |
0.338 |
|
| 2006 |
Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R, Weber BL, Nathanson KL, Phillips DJ, Herlyn M, Schadendorf D, Dummer R. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Research / Sponsored by the European Society For Pigment Cell Research and the International Pigment Cell Society. 19: 290-302. PMID 16827748 DOI: 10.1111/J.1600-0749.2006.00322.X |
0.342 |
|
| 2006 |
Bertozzi CC, Chang CY, Jairaj S, Shan X, Huang J, Weber BL, Chu CS, Carroll RG. Multiple initial culture conditions enhance the establishment of cell lines from primary ovarian cancer specimens. In Vitro Cellular & Developmental Biology. Animal. 42: 58-62. PMID 16759149 DOI: 10.1290/0512084.1 |
0.311 |
|
| 2006 |
Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'brien-Jenkins A, Katsaros D, Hatzigeorgiou A, ... ... Weber BL, et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proceedings of the National Academy of Sciences of the United States of America. 103: 9136-41. PMID 16754881 DOI: 10.1073/Pnas.0508889103 |
0.37 |
|
| 2006 |
Zhang L, Huang J, Yang N, Liang S, Barchetti A, Giannakakis A, Cadungog MG, O'Brien-Jenkins A, Massobrio M, Roby KF, Katsaros D, Gimotty P, Butzow R, Weber BL, Coukos G. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Research. 66: 4627-35. PMID 16651413 DOI: 10.1158/0008-5472.Can-05-4527 |
0.457 |
|
| 2006 |
Pierce LJ, Levin AM, Rebbeck TR, Ben-David MA, Friedman E, Solin LJ, Harris EE, Gaffney DK, Haffty BG, Dawson LA, Narod SA, Olivotto IA, Eisen A, Whelan TJ, Olopade OI, ... ... Weber BL, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2437-43. PMID 16636335 DOI: 10.1200/Jco.2005.02.7888 |
0.51 |
|
| 2006 |
Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genetics. 9: 87-92. PMID 16612058 DOI: 10.1159/000091485 |
0.354 |
|
| 2006 |
Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, ... ... Weber BL, et al. A genome wide linkage search for breast cancer susceptibility genes. Genes, Chromosomes & Cancer. 45: 646-55. PMID 16575876 DOI: 10.1002/Gcc.20330 |
0.587 |
|
| 2006 |
Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, Isaacs C, Weber B, Foulkes WD, Moller P, Rosen B, Kim-Sing C, Gershoni-Baruch R, Ainsworth P, Daly M, et al. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Research : Bcr. 8: R15. PMID 16563180 DOI: 10.1186/Bcr1387 |
0.548 |
|
| 2006 |
Domchek SM, Friebel TM, Neuhausen SL, Wagner T, Evans G, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson GE, Van't Veer L, Lynch HT, Olopade OI, Weber BL, et al. Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. The Lancet. Oncology. 7: 223-9. PMID 16510331 DOI: 10.1016/S1470-2045(06)70585-X |
0.485 |
|
| 2006 |
Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 863-71. PMID 16484695 DOI: 10.1200/Jco.2005.03.6772 |
0.484 |
|
| 2006 |
Domchek SM, Armstrong K, Weber BL. Clinical management of BRCA1 and BRCA2 mutation carriers. Nature Clinical Practice. Oncology. 3: 2-3. PMID 16407858 DOI: 10.1038/Sj.Onc.1209881 |
0.571 |
|
| 2006 |
Crockford GP, Linger R, Hockley S, Dudakia D, Johnson L, Huddart R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, ... ... Weber BL, et al. Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Human Molecular Genetics. 15: 443-51. PMID 16407372 DOI: 10.1093/Hmg/Ddi459 |
0.324 |
|
| 2006 |
Colilla S, Kantoff PW, Neuhausen SL, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Brown M, Weber BL, Rebbeck TR. The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers. Carcinogenesis. 27: 599-605. PMID 16244359 DOI: 10.1093/Carcin/Bgi246 |
0.504 |
|
| 2006 |
Brookman-Amissah N, Duchesnes C, Williamson MP, Wang Q, Ahmed A, Feneley MR, Mackay A, Freeman A, Fenwick K, Iravani M, Weber B, Ashworth A, Masters JR. Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH. Prostate Cancer and Prostatic Diseases. 8: 335-43. PMID 16130014 DOI: 10.1038/Sj.Pcan.4500826 |
0.35 |
|
| 2006 |
Nkondjock A, Ghadirian P, Kotsopoulos J, Lubinski J, Lynch H, Kim-Sing C, Horsman D, Rosen B, Isaacs C, Weber B, Foulkes W, Ainsworth P, Tung N, Eisen A, Friedman E, et al. Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. 118: 103-7. PMID 16032702 DOI: 10.1002/Ijc.21296 |
0.539 |
|
| 2006 |
Domchek SM, Merillat SL, Tigges J, Tweed AJ, Weinar M, Stopfer J, Weber BL. Sex ratio skewing of offspring in families with hereditary susceptibility to breast cancer. Journal of Medical Genetics. 42: 511-3. PMID 15937087 DOI: 10.1136/JMG.2004.027722 |
0.414 |
|
| 2005 |
Metcalfe KA, Foulkes WD, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. Hereditary Cancer in Clinical Practice. 3: 53-7. PMID 20223030 DOI: 10.1186/1897-4287-3-2-53 |
0.566 |
|
| 2005 |
Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, Zaks TZ, Weber BL. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Research : Bcr. 7: R1186-98. PMID 16457699 DOI: 10.1186/Bcr1356 |
0.511 |
|
| 2005 |
Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, ... ... Weber BL, et al. The Y deletion gr/gr and susceptibility to testicular germ cell tumor. American Journal of Human Genetics. 77: 1034-43. PMID 16380914 DOI: 10.1086/498455 |
0.369 |
|
| 2005 |
Armstrong K, Weber B, Ubel PA, Peters N, Holmes J, Schwartz JS. Individualized survival curves improve satisfaction with cancer risk management decisions in women with BRCA1/2 mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9319-28. PMID 16361631 DOI: 10.1200/Jco.2005.06.119 |
0.427 |
|
| 2005 |
Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, et al. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7491-6. PMID 16234515 DOI: 10.1200/Jco.2004.00.7138 |
0.538 |
|
| 2005 |
Rebbeck TR, Friebel T, Wagner T, Lynch HT, Garber JE, Daly MB, Isaacs C, Olopade OI, Neuhausen SL, van 't Veer L, Eeles R, Evans DG, Tomlinson G, Matloff E, Narod SA, ... ... Weber BL, et al. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7804-10. PMID 16219936 DOI: 10.1200/Jco.2004.00.8151 |
0.524 |
|
| 2005 |
Kotsopoulos J, Olopado OI, Ghadirian P, Lubinski J, Lynch HT, Isaacs C, Weber B, Kim-Sing C, Ainsworth P, Foulkes WD, Eisen A, Sun P, Narod SA. Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 7: R833-43. PMID 16168130 DOI: 10.1186/Bcr1293 |
0.537 |
|
| 2005 |
Jönsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR, Greshock JD, Luts L, Olsson H, Rahman N, Stratton M, Ringnér M, Borg A, Weber BL. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Research. 65: 7612-21. PMID 16140926 DOI: 10.1158/0008-5472.Can-05-0570 |
0.468 |
|
| 2005 |
Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G, Teague J, Butler A, Edkins S, Stevens C, Parker A, O'Meara S, Avis T, Barthorpe S, Brackenbury L, ... ... Weber BL, et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Research. 65: 7591-5. PMID 16140923 DOI: 10.1158/0008-5472.Can-05-1855 |
0.434 |
|
| 2005 |
DeMichele A, Aplenc R, Botbyl J, Colligan T, Wray L, Klein-Cabral M, Foulkes A, Gimotty P, Glick J, Weber B, Stadtmauer E, Rebbeck TR. Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5552-9. PMID 16110016 DOI: 10.1200/Jco.2005.06.208 |
0.376 |
|
| 2005 |
Wang C, Fan S, Li Z, Fu M, Rao M, Ma Y, Lisanti MP, Albanese C, Katzenellenbogen BS, Kushner PJ, Weber B, Rosen EM, Pestell RG. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity. Cancer Research. 65: 6557-67. PMID 16061635 DOI: 10.1158/0008-5472.Can-05-0486 |
0.404 |
|
| 2005 |
Kotsopoulos J, Lubinski J, Lynch HT, Neuhausen SL, Ghadirian P, Isaacs C, Weber B, Kim-Sing C, Foulkes WD, Gershoni-Baruch R, Ainsworth P, Friedman E, Daly M, Garber JE, Karlan B, et al. Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes & Control : Ccc. 16: 667-74. PMID 16049805 DOI: 10.1007/S10552-005-1724-1 |
0.541 |
|
| 2005 |
Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C, Friedman E, Randall S, Pasini B, Ainsworth P, Gershoni-Baruch R, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. International Journal of Cancer. Journal International Du Cancer. 117: 988-91. PMID 15986445 DOI: 10.1002/Ijc.21273 |
0.548 |
|
| 2005 |
Mosse YP, Greshock J, Weber BL, Maris JM. Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era. Cancer Letters. 228: 83-90. PMID 15967571 DOI: 10.1016/J.Canlet.2005.02.052 |
0.329 |
|
| 2005 |
Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, Bignell G, Teague J, Smith R, Stevens C, O'Meara S, Parker A, Tarpey P, Avis T, Barthorpe A, ... ... Weber BL, et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nature Genetics. 37: 590-2. PMID 15908952 DOI: 10.1038/Ng1571 |
0.532 |
|
| 2005 |
Valle L, Cascón A, Melchor L, Otero I, Rodríguez-Perales S, Sánchez L, Cruz Cigudosa J, Robledo M, Weber B, Urioste M, Benítez J. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) family. European Journal of Human Genetics : Ejhg. 13: 570-8. PMID 15756303 DOI: 10.1038/Sj.Ejhg.5201371 |
0.326 |
|
| 2005 |
Metcalfe KA, Lynch HT, Ghadirian P, Tung N, Olivotto IA, Foulkes WD, Warner E, Olopade O, Eisen A, Weber B, McLennan J, Sun P, Narod SA. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecologic Oncology. 96: 222-6. PMID 15589605 DOI: 10.1016/J.Ygyno.2004.09.039 |
0.548 |
|
| 2005 |
Herold CI, Goldfeder KL, Tigges J, Stopfer JE, Weber BL, Domchek SM. Factors that influence genetic testing outcomes in high-risk breast/ovarian families Journal of Clinical Oncology. 23: 9616-9616. DOI: 10.1200/jco.2005.23.16_suppl.9616 |
0.303 |
|
| 2005 |
Pujana M, Han J, Starita L, Tewari M, Ahn J, Assmann V, ElShamy W, Rual J, Gelman R, Gunsalus K, Greenberg R, Bohian B, Bertin N, Ayivi-Guedehoussou N, Nathanson K, ... Weber B, et al. A model of the BRCA1/BRCA2 network Breast Cancer Research. 7: 1-1. DOI: 10.1186/Bcr1195 |
0.485 |
|
| 2005 |
Greshock J, Mosse Y, Naylor TL, Brose M, Huang J, Fakharzadeh S, Martin AM, Athenasiadis G, Ward R, Medina A, Diskin S, Zaks TZ, Brown J, Maris JM, Weber BL. O25: Analysis of the genetic similarity of 10 cancer types using genome copy number data European Journal of Medical Genetics. 48: 492-493. DOI: 10.1016/J.Ejmg.2005.10.064 |
0.341 |
|
| 2004 |
Schneider KA, DiGianni LM, Patenaude AF, Klar N, Stopfer JE, Calzone KA, Li FP, Weber BL, Garber JE. Accuracy of cancer family histories: comparison of two breast cancer syndromes. Genetic Testing. 8: 222-8. PMID 15727243 DOI: 10.1089/Gte.2004.8.222 |
0.513 |
|
| 2004 |
Huang J, Domchek SM, Brose MS, Rebbeck TR, Nathanson KL, Weber BL. Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers Journal of Medical Genetics. 41. PMID 15520402 DOI: 10.1136/Jmg.2004.022913 |
0.484 |
|
| 2004 |
Stephens P, Hunter C, Bignell G, Edkins S, Davies H, Teague J, Stevens C, O'Meara S, Smith R, Parker A, Barthorpe A, Blow M, Brackenbury L, Butler A, Clarke O, ... ... Weber BL, et al. Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature. 431: 525-6. PMID 15457249 DOI: 10.1038/431525B |
0.423 |
|
| 2004 |
Tsavachidou D, Coleman ML, Athanasiadis G, Li S, Licht JD, Olson MF, Weber BL. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. Cancer Research. 64: 5556-9. PMID 15313890 DOI: 10.1158/0008-5472.Can-04-1669 |
0.72 |
|
| 2004 |
Jernström H, Lubinski J, Lynch HT, Ghadirian P, Neuhausen S, Isaacs C, Weber BL, Horsman D, Rosen B, Foulkes WD, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 96: 1094-8. PMID 15265971 DOI: 10.1093/Jnci/Djh211 |
0.55 |
|
| 2004 |
Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod SA. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2328-35. PMID 15197194 DOI: 10.1200/Jco.2004.04.033 |
0.557 |
|
| 2004 |
Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Research. 64: 3790-7. PMID 15172985 DOI: 10.1158/0008-5472.Can-03-3009 |
0.522 |
|
| 2004 |
Rapley EA, Hockley S, Warren W, Johnson L, Huddart R, Crockford G, Forman D, Leahy MG, Oliver DT, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, ... ... Weber BL, et al. Somatic mutations of KIT in familial testicular germ cell tumours. British Journal of Cancer. 90: 2397-401. PMID 15150569 DOI: 10.1038/Sj.Bjc.6601880 |
0.407 |
|
| 2004 |
Lubinski J, Phelan CM, Ghadirian P, Lynch HT, Garber J, Weber B, Tung N, Horsman D, Isaacs C, Monteiro AN, Sun P, Narod SA. Cancer variation associated with the position of the mutation in the BRCA2 gene. Familial Cancer. 3: 1-10. PMID 15131399 DOI: 10.1023/B:Fame.0000026816.32400.45 |
0.538 |
|
| 2004 |
Ghadirian P, Lubinski J, Lynch H, Neuhausen SL, Weber B, Isaacs C, Baruch RG, Randall S, Ainsworth P, Friedman E, Freidman E, Horsman D, Tonin P, Foulkes WD, Tung N, et al. Smoking and the risk of breast cancer among carriers of BRCA mutations. International Journal of Cancer. Journal International Du Cancer. 110: 413-6. PMID 15095307 DOI: 10.1002/Ijc.20106 |
0.496 |
|
| 2004 |
Lakhani SR, Manek S, Penault-Llorca F, Flanagan A, Arnout L, Merrett S, McGuffog L, Steele D, Devilee P, Klijn JGM, Meijers-Heijboer H, Radice P, Pilotti S, Nevanlinna H, Butzow R, ... ... Weber B, et al. Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers Clinical Cancer Research. 10: 2473-2481. PMID 15073127 DOI: 10.1158/1078-0432.Ccr-1029-3 |
0.446 |
|
| 2004 |
Li H, Giger ML, Huo Z, Olopade OI, Lan L, Weber BL, Bonta I. Computerized analysis of mammographic parenchymal patterns for assessing breast cancer risk: effect of ROI size and location. Medical Physics. 31: 549-55. PMID 15070253 DOI: 10.1118/1.1644514 |
0.488 |
|
| 2004 |
Foulkes WD, Metcalfe K, Sun P, Hanna WM, Lynch HT, Ghadirian P, Tung N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Bégin LR, Narod SA. Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2029-34. PMID 15041722 DOI: 10.1158/1078-0432.Ccr-03-1061 |
0.508 |
|
| 2004 |
Armstrong K, Schwartz JS, Randall T, Rubin SC, Weber B. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1045-54. PMID 14981106 DOI: 10.1200/Jco.2004.06.090 |
0.363 |
|
| 2004 |
Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1055-62. PMID 14981104 DOI: 10.1200/Jco.2004.04.188 |
0.55 |
|
| 2004 |
Bignell GR, Huang J, Greshock J, Watt S, Butler A, West S, Grigorova M, Jones KW, Wei W, Stratton MR, Futreal PA, Weber B, Shapero MH, Wooster R. High-resolution analysis of DNA copy number using oligonucleotide microarrays. Genome Research. 14: 287-95. PMID 14762065 DOI: 10.1101/Gr.2012304 |
0.366 |
|
| 2004 |
Grushko TA, Dignam JJ, Das S, Blackwood AM, Perou CM, Ridderstråle KK, Anderson KN, Wei MJ, Adams AJ, Hagos FG, Sveen L, Lynch HT, Weber BL, Olopade OI. MYC is amplified in BRCA1-associated breast cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 499-507. PMID 14760071 DOI: 10.1158/1078-0432.Ccr-0976-03 |
0.554 |
|
| 2004 |
Greshock J, Naylor TL, Margolin A, Diskin S, Cleaver SH, Futreal PA, deJong PJ, Zhao S, Liebman M, Weber BL. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis Genome Research. 14: 179-187. PMID 14672980 DOI: 10.1101/Gr.1847304 |
0.343 |
|
| 2004 |
Domchek SM, Tweed AJ, Stopfer J, Weiner M, Weber BL. Physician and patient-related barriers to participation in genetic testing for breast cancer susceptibility Journal of Clinical Oncology. 22: 9582-9582. DOI: 10.1200/jco.2004.22.90140.9582 |
0.343 |
|
| 2003 |
Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, et al. The Cancer Genetics Network: recruitment results and pilot studies. Community Genetics. 6: 171-7. PMID 15237201 DOI: 10.1159/000078165 |
0.414 |
|
| 2003 |
Mosse Y, Greshock J, King A, Khazi D, Weber BL, Maris JM. Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma. The Lancet. Oncology. 4: 769-71. PMID 14662434 DOI: 10.1016/S1470-2045(03)01283-X |
0.334 |
|
| 2003 |
Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N, Olopade O, Weber B, McLennan J, Olivotto IA, Sun P, Chappuis PO, Bégin LR, Brunet JS, Narod SA. Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma. Cancer. 98: 1569-77. PMID 14534871 DOI: 10.1002/Cncr.11688 |
0.386 |
|
| 2003 |
Armstrong K, Weber B, FitzGerald G, Hershey JC, Pauly MV, Lemaire J, Subramanian K, Asch DA. Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination. American Journal of Medical Genetics. Part A. 120: 359-64. PMID 12838555 DOI: 10.1002/Ajmg.A.20025 |
0.459 |
|
| 2003 |
Wooster R, Weber BL. Breast and ovarian cancer. The New England Journal of Medicine. 348: 2339-47. PMID 12788999 DOI: 10.1056/Nejmra012284 |
0.55 |
|
| 2003 |
Martin AM, Kanetsky PA, Amirimani B, Colligon TA, Athanasiadis G, Shih HA, Gerrero MR, Calzone K, Rebbeck TR, Weber BL. Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1? Journal of Medical Genetics. 40. PMID 12676907 |
0.49 |
|
| 2003 |
Schutte M, Seal S, Barfoot R, Meijers-Heijboer H, Wasielewski M, Evans DG, Eccles D, Meijers C, Lohman F, Klijn J, Van Den Ouweland A, Futreal PA, Nathanson KL, Weber BL, Easton DF, et al. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility American Journal of Human Genetics. 72: 1023-1028. PMID 12610780 DOI: 10.1086/373965 |
0.559 |
|
| 2003 |
Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL. Application of breast cancer risk prediction models in clinical practice. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 593-601. PMID 12586794 DOI: 10.1200/Jco.2003.07.007 |
0.523 |
|
| 2003 |
Armstrong K, Weber B, Stopfer J, Calzone K, Putt M, Coyne J, Schwartz JS. Early use of clinical BRCA1/2 testing: associations with race and breast cancer risk. American Journal of Medical Genetics. Part A. 117: 154-60. PMID 12567413 DOI: 10.1002/Ajmg.A.10928 |
0.503 |
|
| 2002 |
Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 94: 1773-9. PMID 12464649 DOI: 10.1093/Jnci/94.23.1773 |
0.554 |
|
| 2002 |
Domchek SM, Weber BL. Recent advances in breast cancer biology. Current Opinion in Oncology. 14: 589-93. PMID 12409647 |
0.436 |
|
| 2002 |
Huo Z, Giger ML, Olopade OI, Wolverton DE, Weber BL, Metz CE, Zhong W, Cummings SA. Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology. 225: 519-26. PMID 12409590 DOI: 10.1148/Radiol.2252010845 |
0.524 |
|
| 2002 |
Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BCRA1 mutation carriers identified in a risk evaluation program Journal of the National Cancer Institute. 94: 1365-1372. PMID 12237282 DOI: 10.1093/Jnci/94.18.1365 |
0.499 |
|
| 2002 |
Armstrong K, Stopfer J, Calzone K, Fitzgerald G, Coyne J, Weber B. What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Genetic Testing. 6: 115-118. PMID 12215250 DOI: 10.1089/10906570260199366 |
0.329 |
|
| 2002 |
Weber BL. Cancer genomics. Cancer Cell. 1: 37-47. PMID 12086886 |
0.312 |
|
| 2002 |
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, ... ... Weber BL, et al. Mutations of the BRAF gene in human cancer. Nature. 417: 949-54. PMID 12068308 DOI: 10.1038/Nature00766 |
0.459 |
|
| 2002 |
Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS. Interest in BRCA1/2 testing in a primary care population. Preventive Medicine. 34: 590-5. PMID 12052018 DOI: 10.1006/Pmed.2002.1022 |
0.398 |
|
| 2002 |
Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. The New England Journal of Medicine. 346: 1616-22. PMID 12023993 DOI: 10.1056/Nejmoa012158 |
0.527 |
|
| 2002 |
Nathanson KL, Shugart YY, Omaruddin R, Szabo C, Goldgar D, Rebbeck TR, Weber BL. CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Human Molecular Genetics. 11: 1327-32. PMID 12019214 DOI: 10.1093/Hmg/11.11.1327 |
0.557 |
|
| 2002 |
Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, ... ... Weber B, et al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nature Genetics. 31: 55-9. PMID 11967536 DOI: 10.1038/Ng879 |
0.523 |
|
| 2002 |
Grushko TA, Blackwood MA, Schumm PL, Hagos FG, Adeyanju MO, Feldman MD, Sanders MO, Weber BL, Olopade OI. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. Cancer Research. 62: 1481-8. PMID 11888924 |
0.378 |
|
| 2002 |
DeMichele A, Weber BL. Risk management in BRCA1 and BRCA2 mutation carriers: lessons learned, challenges posed. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 1164-6. PMID 11870156 DOI: 10.1200/Jco.2002.20.5.1164 |
0.356 |
|
| 2002 |
Benazon NR, Coyne JC, Calzone KA, Weber BL. Why not to screen high-risk women anticipating BRCA1/BRCA2 testing for psychological distress. Journal of Consulting and Clinical Psychology. 70: 258. PMID 11860053 DOI: 10.1037//0022-006X.70.1.258 |
0.334 |
|
| 2002 |
Shih HA, Couch FJ, Nathanson KL, Anne Blackwood M, Rebbeck TR, Armstrong KA, Calzone K, Stopfer J, Seal S, Stratton MR, Weber BL. BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic Journal of Clinical Oncology. 20: 994-999. PMID 11844822 DOI: 10.1200/Jco.20.4.994 |
0.576 |
|
| 2002 |
Kristiansen M, Langerød A, Knudsen GP, Weber BL, Børresen-Dale AL, Orstavik KH. High frequency of skewed X inactivation in young breast cancer patients. Journal of Medical Genetics. 39: 30-3. PMID 11826021 DOI: 10.1136/Jmg.39.1.30 |
0.45 |
|
| 2002 |
Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, ... ... Weber BL, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proceedings of the National Academy of Sciences of the United States of America. 99: 827-31. PMID 11792833 DOI: 10.1073/Pnas.012584499 |
0.536 |
|
| 2001 |
Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R, Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI, Foulkes WD, Karlan B, et al. Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics. 11: 635-8. PMID 11668223 DOI: 10.1097/00008571-200110000-00010 |
0.438 |
|
| 2001 |
Unger MA, Rishi M, Clemmer VB, Hartman JL, Keiper EA, Greshock JD, Chodosh LA, Liebman MN, Weber BL. Characterization of adjacent breast tumors using oligonucleotide microarrays Breast Cancer Research. 3: 336-341. PMID 11597324 DOI: 10.1186/Bcr317 |
0.698 |
|
| 2001 |
Eisen A, Weber BL. Prophylactic mastectomy for women with BRCA1 and BRCA2 mutations--facts and controversy. The New England Journal of Medicine. 345: 207-8. PMID 11463017 DOI: 10.1056/Nejm200107193450309 |
0.537 |
|
| 2001 |
Narod SA, Sun P, Ghadirian P, Lynch H, Isaacs C, Garber J, Weber B, Karlan B, Fishman D, Rosen B, Tung N, Neuhausen SL. Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet (London, England). 357: 1467-70. PMID 11377596 DOI: 10.1016/S0140-6736(00)04642-0 |
0.494 |
|
| 2001 |
Nathanson KL, Wooster R, Weber BL, Nathanson KN. Breast cancer genetics: what we know and what we need. Nature Medicine. 7: 552-6. PMID 11329055 DOI: 10.1038/87876 |
0.565 |
|
| 2001 |
Martin AM, Blackwood MA, Antin-Ozerkis D, Shih HA, Calzone K, Colligon TA, Seal S, Collins N, Stratton MR, Weber BL, Nathanson KL. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 19: 2247-53. PMID 11304778 DOI: 10.1200/Jco.2001.19.8.2247 |
0.499 |
|
| 2001 |
Nathanson KL, Weber BL. "Other" breast cancer susceptibility genes: searching for more holy grail. Human Molecular Genetics. 10: 715-20. PMID 11257104 DOI: 10.1093/Hmg/10.7.715 |
0.591 |
|
| 2001 |
Armstrong K, Weber BL. Breast cancer screening for high-risk women: too little, too late? Journal of Clinical Oncology. 19: 919-920. PMID 11181652 DOI: 10.1200/Jco.2001.19.4.919 |
0.48 |
|
| 2001 |
Narod SA, Brunet JS, Ghadirian P, Robson M, Heimdal K, Neuhausen SL, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H. Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (London, England). 356: 1876-81. PMID 11130383 DOI: 10.1016/S0140-6736(00)03258-X |
0.577 |
|
| 2000 |
Unger MA, Weber BL. Recent advances in breast cancer biology. Current Opinion in Oncology. 12: 521-5. PMID 11085450 DOI: 10.1097/00001622-200011000-00002 |
0.733 |
|
| 2000 |
Pierce LJ, Strawderman M, Narod SA, Oliviotto I, Eisen A, Dawson L, Gaffney D, Solin LJ, Nixon A, Garber J, Berg C, Isaacs C, Heimann R, Olopade OI, Haffty B, ... Weber BL, et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 3360-9. PMID 11013276 DOI: 10.1200/Jco.2000.18.19.3360 |
0.434 |
|
| 2000 |
Unger MA, Nathanson KL, Calzone K, Antin-Ozerkis D, Shih HA, Martin AM, Lenoir GM, Mazoyer S, Weber BL. Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. American Journal of Human Genetics. 67: 841-50. PMID 10978226 DOI: 10.1086/303076 |
0.752 |
|
| 2000 |
Rahman N, Teare MD, Seal S, Renard H, Mangion J, Cour C, Thompson D, Shugart Y, Eccles D, Devilee P, Meijers H, Nathanson KL, Neuhausen SL, Weber B, Chang-Claude J, et al. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22. Oncogene. 19: 4170-4173. PMID 10962578 DOI: 10.1038/Sj.Onc.1203735 |
0.48 |
|
| 2000 |
Houvras Y, Benezra M, Zhang H, Manfredi JJ, Weber BL, Licht JD. BRCA1 physically and functionally interacts with ATF1. The Journal of Biological Chemistry. 275: 36230-7. PMID 10945975 DOI: 10.1074/Jbc.M002539200 |
0.383 |
|
| 2000 |
Martin AM, Weber BL. Genetic and hormonal risk factors in breast cancer Journal of the National Cancer Institute. 92: 1126-1135. PMID 10904085 DOI: 10.1093/Jnci/92.14.1126 |
0.57 |
|
| 2000 |
Weber BL, Nathanson KL. Low penetrance genes associated with increased risk for breast cancer. European Journal of Cancer (Oxford, England : 1990). 36: 1193-9. PMID 10882856 DOI: 10.1016/S0959-8049(00)00082-4 |
0.581 |
|
| 2000 |
Rohlfs EM, Puget N, Graham ML, Weber BL, Garber JE, Skrzynia C, Halperin JL, Lenoir GM, Silverman LM, Mazoyer S. An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10 Genes Chromosomes and Cancer. 28: 300-307. PMID 10862036 DOI: 10.1002/1098-2264(200007)28:3<300::Aid-Gcc8>3.0.Co;2-1 |
0.541 |
|
| 2000 |
Mazoyer S, Leary J, Kirk J, Fleischmann E, Wagner T, Claes K, Messiaen L, Foulkes W, Desrochers M, Simard J, Phelan CM, Kwan E, Narod SA, Vahteristo P, Nevanlinna H, ... ... Weber BL, et al. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographicaly diverse populations American Journal of Human Genetics. 67: 207-212. PMID 10827109 DOI: 10.1086/302974 |
0.711 |
|
| 2000 |
Eisen A, Rebbeck TR, Wood WC, Weber BL. Prophylactic surgery in women with a hereditary to breast and ovarian cancer Journal of Clinical Oncology. 18: 1980-1995. PMID 10784640 DOI: 10.1200/Jco.2000.18.9.1980 |
0.471 |
|
| 2000 |
Armstrong K, Eisen A, Weber B. Assessing the risk of breast cancer. The New England Journal of Medicine. 342: 564-571. PMID 10684916 DOI: 10.1056/Nejm200002243420807 |
0.508 |
|
| 2000 |
Liede A, Cohen B, Black DM, Davidson RH, Renwick A, Hoodfar E, Olopade OI, Micek M, Anderson V, De Mey R, Fordyce A, Warner E, Dann JL, King MC, Weber B, et al. Evidence of a founder BRCA1 mutation in Scotland. British Journal of Cancer. 82: 705-11. PMID 10682686 DOI: 10.1054/Bjoc.1999.0984 |
0.537 |
|
| 2000 |
Budhram-Mahadeo V, Ndisang D, Ward T, Weber BL, Latchman DS. The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells. Oncogene. 18: 6684-91. PMID 10597274 DOI: 10.1038/Sj.Onc.1203072 |
0.468 |
|
| 2000 |
Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, el-Deiry WS. BRCA1 signals ARF-dependent stabilization and coactivation of p53. Oncogene. 18: 6605-14. PMID 10597265 DOI: 10.1038/Sj.Onc.1203284 |
0.351 |
|
| 2000 |
Kristiansen M, Langer A, Knudsen G, Weber B, Børresen-Dale A, Ørstavik K. X chromosome inactivation pattern in female patients with breast cancer Breast Cancer Research. 2: 1-1. DOI: 10.1186/Bcr148 |
0.44 |
|
| 2000 |
Weber B. Genetic testing for BRCA1 and BRCA2 mutations - ready for implementation? Breast Cancer Research. 2: 1-2. DOI: 10.1186/Bcr128 |
0.396 |
|
| 2000 |
Coyne JC, Benazon NR, Gaba CG, Calzone K, Weber BL. Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. Journal of Consulting and Clinical Psychology. 68: 864-874. DOI: 10.1037/0022-006X.68.5.864 |
0.467 |
|
| 2000 |
Kim C, Gumbs A, Komarnicky L, Carter D, Hutter R, Palazzo J, McCue P, Goodman R, Haffty B, Rebbeck T, Weber B, Turner B. Predicted germline BRCA1/BRCA2 mutations and second primary ipsilateral breast cancers in young women with pure ductal carcinoma in-situ treated with breast conserving therapy International Journal of Radiation Oncology*Biology*Physics. 48: 142-143. DOI: 10.1016/S0360-3016(00)80079-6 |
0.525 |
|
| 1999 |
Jernström H, Lerman C, Ghadirian P, Lynch HT, Weber B, Garber J, Daly M, Olopade OI, Foulkes WD, Warner E, Brunet JS, Narod SA. Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2. The Lancet. 354: 1846-1850. PMID 10584720 DOI: 10.1016/S0140-6736(99)04336-6 |
0.519 |
|
| 1999 |
Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Journal of the National Cancer Institute. 91: 1475-9. PMID 10469748 DOI: 10.1093/Jnci/91.17.1475 |
0.565 |
|
| 1999 |
Nathanson KL, Antin-Ozerkis D, Couch FJ, Weber BL. I1307K APC variant in non-Ashkenazi Jewish women affected with breast cancer. American Journal of Medical Genetics. 85: 189-190. PMID 10406676 DOI: 10.1002/(Sici)1096-8628(19990716)85:2<189::Aid-Ajmg17>3.0.Co;2-H |
0.505 |
|
| 1999 |
Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. American Journal of Human Genetics. 64: 1371-7. PMID 10205268 DOI: 10.1086/302366 |
0.559 |
|
| 1999 |
Carroll BT, Couch FJ, Rebbeck TR, Weber BL. Polymorphisms in PTEN in breast cancer families Journal of Medical Genetics. 36: 94-96. PMID 10051004 DOI: 10.1136/Jmg.36.2.94 |
0.572 |
|
| 1999 |
Eisen A, Weber BL. Prophylactic mastectomy--the price of fear. The New England Journal of Medicine. 340: 137-8. PMID 9887166 DOI: 10.1056/Nejm199901143400209 |
0.49 |
|
| 1998 |
Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Molecular Cell. 2: 317-28. PMID 9774970 DOI: 10.1016/S1097-2765(00)80276-2 |
0.525 |
|
| 1998 |
Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, ... ... Weber B, et al. The APCI1307K allele and breast cancer risk. Nature Genetics. 20: 13-4. PMID 9731522 DOI: 10.1038/1666 |
0.514 |
|
| 1998 |
Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM, Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy JA, Slamon DJ. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 2659-71. PMID 9704716 DOI: 10.1200/Jco.1998.16.8.2659 |
0.392 |
|
| 1998 |
Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ, Farid LM, Venter D, Antoniou A, Storfer-Isser A, Smyth E, Steel CM, Haites N, Scott RJ, Goldgar D, ... ... Weber B, et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. Journal of the National Cancer Institute. 90: 1138-45. PMID 9701363 DOI: 10.1093/Jnci/90.15.1138 |
0.591 |
|
| 1998 |
Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, ... Weber BL, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. Journal of the National Cancer Institute. 90: 761-6. PMID 9605646 DOI: 10.1093/Jnci/90.10.761 |
0.512 |
|
| 1998 |
Blackwood MA, Weber BL. BRCA1 and BRCA2: from molecular genetics to clinical medicine. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 1969-77. PMID 9586917 DOI: 10.1200/JCO.1998.16.5.1969 |
0.502 |
|
| 1998 |
Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, ... ... Weber B, et al. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. American Journal of Human Genetics. 62: 1381-8. PMID 9585613 DOI: 10.1086/301885 |
0.533 |
|
| 1998 |
Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL, El-Deiry WS. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 16: 1713-21. PMID 9582019 DOI: 10.1038/Sj.Onc.1201932 |
0.434 |
|
| 1998 |
Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. American Journal of Human Genetics. 62: 676-89. PMID 9497246 DOI: 10.1086/301749 |
0.564 |
|
| 1998 |
Andersen TI, Eiken HG, Couch F, Kaada G, Skrede M, Johnsen H, Aloysius TA, Tveit KM, Tranebjaerg L, Dørum A, Møller P, Weber BL, Børresen-Dale AL. Constant denaturant gel electrophoresis (CDGE) in BRCA1 mutation screening. Human Mutation. 11: 166-74. PMID 9482581 DOI: 10.1002/(Sici)1098-1004(1998)11:2<166::Aid-Humu10>3.0.Co;2-X |
0.503 |
|
| 1997 |
DeMichele A, Weber BL. Recent advances in breast cancer biology Current Opinion in Oncology. 9: 499-504. PMID 9370069 DOI: 10.1097/00001622-199711000-00002 |
0.526 |
|
| 1997 |
Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Wu GS, Licht JD, Weber BL, El-Deiry WS. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the cdk-inhibitor p21waf1/cip1 Nature. 389: 187-190. PMID 9296497 DOI: 10.1038/38291 |
0.467 |
|
| 1997 |
Helvie MA, Roubidoux MA, Weber BL, Merajver SD. Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: Initial experience American Journal of Roentgenology. 168: 1599-1602. PMID 9168735 DOI: 10.2214/Ajr.168.6.9168735 |
0.464 |
|
| 1997 |
Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. The New England Journal of Medicine. 336: 1409-15. PMID 9145677 DOI: 10.1056/Nejm199705153362002 |
0.546 |
|
| 1997 |
Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, Farid LM, Couch FJ, Wilson RB, Weber BL. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Molecular and Cellular Biology. 17: 444-52. PMID 8972225 DOI: 10.1128/Mcb.17.1.444 |
0.427 |
|
| 1997 |
Rohlfs EM, Learning WG, Friedman KJ, Couch FJ, Weber BL, Silverman LM. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis Clinical Chemistry. 43: 24-29. DOI: 10.1093/Clinchem/43.1.24 |
0.47 |
|
| 1997 |
Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH-, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, ... ... Weber B, et al. BRCA1 Sequence Analysis in Women at High Risk for Susceptibility Mutations: Risk Factor Analysis and Implications for Genetic Testing Jama. 278: 1242-1250. DOI: 10.1001/Jama.1997.03550150046034 |
0.562 |
|
| 1996 |
Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families Nature Medicine. 2: 1179-1183. PMID 8898735 DOI: 10.1038/Nm1196-1179 |
0.562 |
|
| 1996 |
Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, Berchuck A, Muto MG, Garber JE, Weber BL, Lynch HT, Boyd J. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. The New England Journal of Medicine. 335: 1413-6. PMID 8875917 DOI: 10.1056/Nejm199611073351901 |
0.464 |
|
| 1996 |
Couch FJ, Rommens JM, Neuhausen SL, Bélanger C, Dumont M, Abel K, Bell R, Berry S, Bogden R, Cannon-Albright L, Farid L, Frye C, Hattier T, Janecki T, Jiang P, ... ... Weber BL, et al. Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13 Genomics. 36: 86-99. PMID 8812419 DOI: 10.1006/Geno.1996.0428 |
0.34 |
|
| 1996 |
Couch FJ, Weber BL. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Human Mutation. 8: 8-18. PMID 8807330 DOI: 10.1002/Humu.1380080102 |
0.532 |
|
| 1996 |
Bennett-Baker PE, Kiousis S, Chandrasekharappa SC, King SE, Abel KJ, Collins FS, Weber BL, Chamberlain JS. Isolation of tetranucleotide repeat polymorphisms flanking the BRCA1 gene. Genomics. 32: 163-7. PMID 8786111 DOI: 10.1006/Geno.1996.0097 |
0.474 |
|
| 1996 |
Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, ... ... Weber BL, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genetics. 13: 123-5. PMID 8673091 DOI: 10.1038/Ng0596-123 |
0.588 |
|
| 1996 |
Weber B. Breast cancer susceptibility genes: Current challenges and future promises Annals of Internal Medicine. 124: 1088-1090. PMID 8633825 DOI: 10.7326/0003-4819-124-12-199606150-00012 |
0.509 |
|
| 1996 |
Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, ... ... Weber B, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds Nature Genetics. 12: 333-337. PMID 8589730 DOI: 10.1038/Ng0396-333 |
0.548 |
|
| 1996 |
Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genetics. 12: 309-11. PMID 8589723 DOI: 10.1038/Ng0396-309 |
0.546 |
|
| 1995 |
Abel KJ, Xu J, Yin GY, Lyons RH, Meisler MH, Weber BL. Mouse Brca1: Localization, sequence analysis and identification of evolutionarily conserved domains Human Molecular Genetics. 4: 2265-2273. PMID 8634697 DOI: 10.1093/Hmg/4.12.2265 |
0.36 |
|
| 1995 |
Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H. Risk modifiers in carriers of BRCA1 mutations. International Journal of Cancer. 64: 394-8. PMID 8550241 DOI: 10.1002/Ijc.2910640608 |
0.542 |
|
| 1995 |
Hoskins KF, Stopfer JE, Calzone KA, Weber BL, Merajver SD, Rebbeck TR, Garber JE. Assessment and Counseling for Women With a Family History of Breast Cancer: A Guide for Clinicians Jama: the Journal of the American Medical Association. 273: 577-585. PMID 7837392 DOI: 10.1001/Jama.1995.03520310075033 |
0.537 |
|
| 1995 |
Hoskins K, Weber BL. The biology of breast cancer. Current Opinion in Oncology. 6: 554-9. PMID 7827164 DOI: 10.1097/00001622-199411000-00004 |
0.518 |
|
| 1995 |
Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genetics. 9: 439-43. PMID 7795652 DOI: 10.1038/Ng0495-439 |
0.521 |
|
| 1995 |
Brody LC, Abel KJ, Castilla LH, Couch FJ, McKinley DR, Yin G, Ho PP, Merajver S, Chandrasekharappa SC, Xu J, Cole JL, Struewing JP, Valdes JM, Collins FS, Weber BL. Construction of a transcription map surrounding the BRCA1 locus of human chromosome 17 Genomics. 25: 238-247. PMID 7774924 DOI: 10.1016/0888-7543(95)80131-5 |
0.32 |
|
| 1995 |
Weber BL, Abel KJ, Couch FJ, Merajver S, Castilla L, Brody LC, Collins FS. Transcript identification in the BRCA1 candidate region Breast Cancer Research and Treatment. 33: 115-124. PMID 7749139 DOI: 10.1007/Bf00682719 |
0.483 |
|
| 1995 |
Couch FJ, Kiousis S, Castilla LH, Xu J, Chandrasekharappa SC, Chamberlain JS, Collins FS, Weber BL. Characterization of 10 new polymorphic dinucleotide repeats and generation of a high-density microsatellite-based physical map of the BRCA1 region of chromosome 17q21. Genomics. 24: 419-24. PMID 7713491 DOI: 10.1006/Geno.1994.1647 |
0.453 |
|
| 1995 |
Weber BL, Vogel C, Jones S, Harvey H, Hutchins L, Bigley J, Hohneker J. Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 2722-30. PMID 7595730 DOI: 10.1200/Jco.1995.13.11.2722 |
0.339 |
|
| 1995 |
Friend S, Borresen AL, Brody L, Casey G, Devilee P, Gayther S, Goldgar D, Murphy P, Weber BL, Wiseman R. Breast cancer information on the web. Nature Genetics. 11: 238-9. PMID 7581445 DOI: 10.1038/Ng1195-238 |
0.476 |
|
| 1995 |
Luna L, Skammelsrud N, Johnsen O, Abel KJ, Weber BL, Prydz H, Kolstø AB. Structural organization and mapping of the human TCF11 gene. Genomics. 27: 237-44. PMID 7557987 DOI: 10.1006/Geno.1995.1037 |
0.307 |
|
| 1995 |
Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ, Weber BL, Chodosh LA. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues Nature Genetics. 11: 17-26. PMID 7550308 DOI: 10.1038/Ng0995-17 |
0.423 |
|
| 1994 |
Weber BL. Familial Breast Cancer Clinical Chemistry. 40: 5-16. PMID 8787076 DOI: 10.1007/978-3-642-79278-6_2 |
0.536 |
|
| 1994 |
Chandrasekharappa SC, Friedman L, King SE, Lee YH, Welsch P, Bowcock AM, Weber BL, King MC, Collins FS. The gene for pancreatic polypeptide (PPY) and the anonymous marker D17S78 are within 45 kb of each other on chromosome 17q21. Genomics. 21: 458-60. PMID 8088848 DOI: 10.1006/Geno.1994.1299 |
0.424 |
|
| 1994 |
Weber BL, Abel KJ, Brody LC, Flejter WL, Chandrasekharappa SC, Couch FJ, Merajver SD, Collins FS. Familial breast cancer: Approaching the isolation of a susceptibility gene Cancer. 74: 1013-1020. PMID 8039134 DOI: 10.1002/1097-0142(19940801)74:3+<1013::Aid-Cncr2820741507>3.0.Co;2-# |
0.517 |
|
| 1994 |
Weber BL. Susceptibility genes for breast cancer. The New England Journal of Medicine. 331: 1523-1524. PMID 7969307 DOI: 10.1056/Nejm199412013312214 |
0.51 |
|
| 1994 |
Castilla LH, Couch FJ, Erdos MR, Hoskins KF, Calzone K, Garber JE, Boyd J, Lubin MB, Deshano ML, Brody LC, Collins FS, Weber BL. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer Nature Genetics. 8: 387-391. PMID 7894491 DOI: 10.1038/Ng1294-387 |
0.538 |
|
| 1994 |
Weber BL, Abel KJ, Couch FJ, Merajver SD, Chandrasekharappa SC, Castilla L, McKinley D, Ho PP, Calzone K, Frank TS. Progress toward isolation of a breast cancer susceptibility gene, BRCA1. Cold Spring Harbor Symposia On Quantitative Biology. 59: 531-6. PMID 7587109 DOI: 10.1101/Sqb.1994.059.01.059 |
0.535 |
|
| 1993 |
Weber BL, Garber JE. Family History and Breast Cancer: Probabilities and Possibilities Jama. 270: 1602-1603. DOI: 10.1001/Jama.1993.03510130108041 |
0.528 |
|
| Show low-probability matches. |